Delivery Order SPE2DB22D1017-SPE2DB25FYPCG
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $5,005.88 firm-fixed-price delivery order (SPE2DB20D1004|SPE2DB23FG3J6) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for 4,561,708,082 units of Simvastatin 20 mg tablets. This delivery order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,495,672 units of Simvastatin 10 mg tablets, a cholesterol medication, with a ceiling value of $1,271.06. The contract is a firm fixed-price arrangement with a period of performance through June 10, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order issued under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is for 4,557,840,952 units of Simvastatin 10 mg tablets, with a ceiling value of $1,260.80. The contract is a firm fixed-price...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,326.92, is for the delivery of Simvastatin 40 mg tablets in quantities of 1,000. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 30, 2023. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
- This contract award is for the delivery of SIMVASTATIN 40 MG TABLET 1000S to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $5,323.86, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of October 25, 2022 and was awarded on October 24, 2022. This appears to be a standalone delivery order, as no set-aside designation is mentioned. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Ezetimibe-Simvastatin 10-40 mg tablets in a quantity of 1,000 units. Valued at $1,091.55 with a firm fixed price structure, this non-set-aside contract is scheduled for completion by September 2, 2025. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Zocor 10 mg tablets (90-count units) at a fixed price ceiling value of $1,329.21. This is a competitively awarded contract with no set-aside designation, with a completion date of August 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,409.89 Firm Fixed Price Delivery Order covers the supply of 4,554,719,577 units of Simvastatin 40 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of September 10, 2021, and was awarded on September 9, 2021. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred fourteen thousand nine hundred ninety-six dollars to Amerisourcebergen Drug Corporation for one thousand tablets of simvastatin 10 mg. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order period of performance spans July 7 through July 10, 2023. As a top pharmaceutical supplier, Amerisourcebergen will deliver the generic cholesterol medication to support the...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zocor 10 mg tablets (90-count units) under a competitive, non-set-aside contract. This delivery order, valued at $1,096.10 with a firm fixed price structure, was awarded on July 28, 2025, with an ultimate completion date of July 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with performance...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYPCGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Simvastatin 20 mg tablets in quantities of 1,000 units. This competitively awarded, non-set-aside delivery order carries a ceiling value of $2,539.58 and is structured as a firm fixed price contract with an ultimate completion date of August 26, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office and primary operations as a major pharmaceutical distributor. This delivery order represents a child contract under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp serves as a critical vendor within the Defense Logistics Agency's Medical Supply Chain, providing a comprehensive portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's federal contract performance demonstrates consistent capability in fulfilling competitive procurement requirements across diverse therapeutic domains, positioning it as a key supplier for the department's pharmaceutical needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 8/25/25 |